BioVie Inc.

Last updated September 27, 2026

Organization details

Legal name
BioVie Inc.
Former names
Nanoantibiotics, INC.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Nevada
Headquarters city
Carson City
Headquarters state / province
Nevada
Headquarters country
United States
Fiscal year end
June
Ticker symbol
BIVI
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001580149
EIN
46-2510769

Board of directors

Chief executives

Cuong Do V · CEO & President
Dates unknown

Board connections

4 of this board's directors also sit on 8 other boards. 5 are in the same sector.

Network of BioVie Inc.'s board connections Celularity Inc. Celularity Inc. CryoPort Inc. CryoPort Inc. Adagene Inc. Adagene Inc. Context Therapeutics Inc. Context Therapeutics I... Halozyme Therapeutics Inc. Halozyme Therapeutics... OptimizeRx Corporation OptimizeRx Corporation Sidus Space Inc. Sidus Space Inc. Spark I Acquisition Corp. Spark I Acquisition Co... Cuong Do V Cuong Do V James Paul Lang James Paul Lang Richard J. Berman Richard J. Berman Robert J. Hariri Robert J. Hariri BioVie Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$49,118
4 purchases by 4 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Aug 28, 2026 KIM JOANNE WENDY Officer (Chief Financial Officer) Open-market purchase +2,500 $2.18 $5,450
Aug 28, 2026 Amy Suzon Chappell Director Open-market purchase +727 $2.16 $1,570
Aug 28, 2026 Palumbo Joseph M Officer (Chief Medical Officer) Open-market purchase +4,843 $2.16 $10,461
Aug 27, 2026 Cuong Do V Director, Officer (President & CEO) Open-market purchase +15,210 $2.08 $31,637
Aug 7, 2025 Cuong Do V Director, Officer (President & CEO) Open-market purchase +5,000 — —
Nov 20, 2024 Sigmund Rogich Director Grant or award +32,700 — —
Nov 20, 2024 Richard J. Berman Director Grant or award +34,200 — —
Jun 24, 2024 Palumbo Joseph M Officer (Chief Medical Officer) Grant or award +116,000 — —
Jun 24, 2024 KIM JOANNE WENDY Officer (Chief Financial Officer) Grant or award +73,000 — —
Jun 24, 2024 Cuong Do V Director, Officer (President & CEO) Grant or award +168,000 — —
Jun 24, 2024 Palumbo Joseph M Officer (Chief Medical Officer) Shares withheld for tax −29,000 $0.47 $13,630
Jun 24, 2024 KIM JOANNE WENDY Officer (Chief Financial Officer) Shares withheld for tax −18,250 $0.47 $8,578
Jun 24, 2024 Cuong Do V Director, Officer (President & CEO) Shares withheld for tax −42,000 $0.47 $19,740
Mar 4, 2024 Cuong Do V Director, Officer (President & CEO) Open-market purchase +10,000 — —
Feb 15, 2024 Palumbo Joseph M Officer (Chief Medical Officer) Shares withheld for tax −2,476 $1.18 $2,922

Organizations in the same sector, closest in location and size first.

Questions about BioVie Inc.

Who is the CEO of BioVie Inc.?

Cuong Do V is BioVie Inc.'s CEO & President.

How many directors are on BioVie Inc.'s board?

BioVie Inc.'s board has 10 directors: Amy Suzon Chappell, Cuong Do V, James Paul Lang, Kameel D. Farag, Michael Edward Sherman, Richard J. Berman, Robert J. Hariri, Sigmund Rogich, Steve Gorlin and Terren S. Peizer.

Are BioVie Inc. insiders buying or selling shares?

Over the last 12 months, BioVie Inc. insiders bought $49,118 of shares in 4 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="biovie-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.